Modified Citrus Pectin Prevents Blood-Brain Barrier Disruption in Mouse Subarachnoid Hemorrhage by Inhibiting Galectin-3

Background and Purpose— Plasma levels of galectin-3—a matricellular protein—are increased after aneurysmal subarachnoid hemorrhage (SAH), but the functional significance remains undetermined. This study was conducted to evaluate whether modified citrus pectin (MCP; galectin-3 inhibitor) prevents post-SAH early brain injury, focusing on blood-brain barrier disruption. Methods— C57BL/6 male adult mice (n=251) underwent sham or filament perforation SAH modeling, followed by a random intracerebroventricular injection of vehicle or drug at 30 minutes post-modeling. First, vehicle-treated and 0.8, 4, 16, or 32 µg MCP-treated mice were assessed by neuroscore and brain water content at 24 and 48 hours post-modeling. Second, Evans blue extravasation, Western blotting, coimmunoprecipitation and immunostaining were performed in vehicle-treated or 4 µg MCP-treated mice at 24 hours post-modeling. Third, vehicle or R-galectin-3 (recombinant galectin-3) was administered to SAH mice simultaneously with vehicle or MCP, and neuroscore and Evans blue extravasation were evaluated at 24 hours post-modeling. Fourth, vehicle or R-galectin-3 was administered to MCP-treated SAH mice at 24 hours, and neuroscore and IgG immunostaining were evaluated at 48 hours post-SAH. Results— Among tested dosages, 4 µg MCP showed the best neuroprotective effects as to preventing neurological impairments and brain edema at 24 to 48 hours post-SAH. Four micrograms MCP attenuated post-SAH blood-brain barrier disruption and galectin-3 upregulation in brain capillary endothelial cells, associated with inactivation of ERK (extracellular signal-related kinase) 1/2, STAT (signal transducer and activator of transcription)-3, and MMP (matrix metalloproteinase)-9, and the consequent preservation of a tight junction protein ZO-1 (zonula occludens-1). Coimmunoprecipitation assay demonstrated physical interactions between galectin-3 and TLR (Toll-like receptor) 4. R-galectin-3 blocked the neuroprotective effects of MCP. Conclusions— MCP prevents post-SAH blood-brain barrier disruption possibly by inhibiting galectin-3, of which the mechanisms may include binding to TLR4 and activating ERK1/2, STAT-3, and MMP-9. This study suggests galectin-3 to be a novel therapeutic target against post-SAH early brain injury.

[1]  Y. Miura,et al.  Dose-Dependent Inhibitory Effects of Cilostazol on Delayed Cerebral Infarction After Aneurysmal Subarachnoid Hemorrhage , 2018, Translational Stroke Research.

[2]  Hirofumi Nishikawa,et al.  Matricellular proteins as possible biomarkers for early brain injury after aneurysmal subarachnoid hemorrhage , 2018, Neural regeneration research.

[3]  Lei Liu,et al.  Selective Toll-Like Receptor 4 Antagonists Prevent Acute Blood-Brain Barrier Disruption After Subarachnoid Hemorrhage in Mice , 2018, Molecular Neurobiology.

[4]  Hirofumi Nishikawa,et al.  Possible Role of Inflammation and Galectin-3 in Brain Injury after Subarachnoid Hemorrhage , 2018, Brain sciences.

[5]  Masato Shiba,et al.  Acute-Phase Plasma Osteopontin as an Independent Predictor for Poor Outcome After Aneurysmal Subarachnoid Hemorrhage , 2018, Molecular Neurobiology.

[6]  Masato Shiba,et al.  Increased Plasma Galectin-3 Preceding the Development of Delayed Cerebral Infarction and Eventual Poor Outcome in Non-Severe Aneurysmal Subarachnoid Hemorrhage , 2018, Translational Stroke Research.

[7]  Lei Liu,et al.  Effects of Tenascin-C Knockout on Cerebral Vasospasm After Experimental Subarachnoid Hemorrhage in Mice , 2017, Molecular Neurobiology.

[8]  Hirofumi Nishikawa,et al.  Implications of periostin in the development of subarachnoid hemorrhage-induced brain injuries , 2017, Neural regeneration research.

[9]  C. Hang,et al.  Inhibition of myeloid differentiation primary response protein 88 provides neuroprotection in early brain injury following experimental subarachnoid hemorrhage , 2017, Scientific Reports.

[10]  Lei Liu,et al.  Role of Periostin in Early Brain Injury After Subarachnoid Hemorrhage in Mice , 2017, Stroke.

[11]  Takeshi Okada,et al.  Toll-like receptor 4 as a possible therapeutic target for delayed brain injuries after aneurysmal subarachnoid hemorrhage , 2017, Neural regeneration research.

[12]  Hidenori Suzuki,et al.  Higher Cerebrospinal Fluid pH may Contribute to the Development of Delayed Cerebral Ischemia after Aneurysmal Subarachnoid Hemorrhage , 2017, Translational Stroke Research.

[13]  M. Norenberg,et al.  Role of Matricellular Proteins in Disorders of the Central Nervous System , 2016, Neurochemical Research.

[14]  Hongyi Liu,et al.  Prognostic value of plasma galectin‐3 levels after aneurysmal subarachnoid hemorrhage , 2016, Brain and behavior.

[15]  Lei Liu,et al.  Deficiency of tenascin-C and attenuation of blood-brain barrier disruption following experimental subarachnoid hemorrhage in mice. , 2016, Journal of neurosurgery.

[16]  M. Emdin,et al.  Inhibition of Galectin-3 Pathway Prevents Isoproterenol-Induced Left Ventricular Dysfunction and Fibrosis in Mice , 2016, Hypertension.

[17]  Zisheng Ai,et al.  Galectin-3 Inhibition Is Associated with Neuropathic Pain Attenuation after Peripheral Nerve Injury , 2016, PloS one.

[18]  Lei Liu,et al.  Anti-Vascular Endothelial Growth Factor Treatment Suppresses Early Brain Injury After Subarachnoid Hemorrhage in Mice , 2016, Molecular Neurobiology.

[19]  K. Blomgren,et al.  Microglia-Secreted Galectin-3 Acts as a Toll-like Receptor 4 Ligand and Contributes to Microglial Activation. , 2015, Cell reports.

[20]  D. Coleman,et al.  Cigarette smoke-induced MMP2 and MMP9 secretion from aortic vascular smooth cells is mediated via the Jak/Stat pathway. , 2015, Human pathology.

[21]  F. Zannad,et al.  The impact of galectin-3 inhibition on aldosterone-induced cardiac and renal injuries. , 2015, JACC. Heart failure.

[22]  S. Gupta,et al.  STAT3 and ERK1/2 Cross‐talk in Leukaemia Inhibitory Factor Mediated Trophoblastic JEG‐3 Cell Invasion and Expression of Mucin 1 and Fos , 2014, American journal of reproductive immunology.

[23]  R. Dempsey,et al.  Galectin-3 enhances angiogenic and migratory potential of microglial cells via modulation of integrin linked kinase signaling , 2013, Brain Research.

[24]  Sachiko Sato,et al.  Galectin-3 Is Required for Resident Microglia Activation and Proliferation in Response to Ischemic Injury , 2012, The Journal of Neuroscience.

[25]  T. Itoh,et al.  Immunohistochemistry-based Cell Cycle Detection (iCCD): A Novel System to Visualize Cell Kinetics on Formalin-fixed Paraffin-embedded Tissues , 2012, The American journal of surgical pathology.

[26]  G. Rabinovich,et al.  Galectin-3 drives oligodendrocyte differentiation to control myelin integrity and function , 2011, Cell Death and Differentiation.

[27]  J. Clements,et al.  Human Immunodeficiency Virus Infection of Human Astrocytes Disrupts Blood–Brain Barrier Integrity by a Gap Junction-Dependent Mechanism , 2011, The Journal of Neuroscience.

[28]  P. Winyard,et al.  Modified Citrus Pectin Reduces Galectin-3 Expression and Disease Severity in Experimental Acute Kidney Injury , 2011, PloS one.

[29]  R. Giffard,et al.  Endotoxin-activated microglia injure brain derived endothelial cells via NF-κB, JAK-STAT and JNK stress kinase pathways , 2011, Journal of Inflammation.

[30]  Volker Seifert,et al.  Inhibition of the JAK-2/STAT3 signaling pathway impedes the migratory and invasive potential of human glioblastoma cells , 2011, Journal of Neuro-Oncology.

[31]  H. Yoon,et al.  Galectin-3 Exerts Cytokine-Like Regulatory Actions through the JAK–STAT Pathway , 2010, The Journal of Immunology.

[32]  John H. Zhang,et al.  Mechanisms of Osteopontin-Induced Stabilization of Blood-Brain Barrier Disruption After Subarachnoid Hemorrhage in Rats , 2010, Stroke.

[33]  L. Watkins,et al.  Toll‐like receptor 4 in CNS pathologies , 2010, Journal of neurochemistry.

[34]  G. Rabinovich,et al.  Galectins: regulators of acute and chronic inflammation , 2010, Annals of the New York Academy of Sciences.

[35]  Vladislav V Glinsky,et al.  Modified citrus pectin anti-metastatic properties: one bullet, multiple targets. , 2009, Carbohydrate research.

[36]  Courtney R. Plumlee,et al.  Inteferons pen the JAK-STAT pathway. , 2008, Seminars in cell & developmental biology.

[37]  John H. Zhang,et al.  Oxidative stress in subarachnoid haemorrhage: significance in acute brain injury and vasospasm. , 2008, Acta neurochirurgica. Supplement.